Scott A Laurie

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Magnetic Resonance

Top Venues

JCO precision oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Alexander W Wyatt, Saskia Litière, Francois-Clement Bidard, Luc Cabel, Lars Dyrskjøt, Chris A Karlovich, Klaus Pantel, Joan Petrie, Reena Philip, Hillary S Andrews, Paz J Vellanki, Sofie H Tolmeijer, Xenia Villalobos Alberu, Christian Alfano, Jan Bogaerts, Emiliano Calvo, Helen X Chen, Rodrigo De Almeida Toledo, Elisabeth G E de Vries, Lesley Seymour, Scott A Laurie, Elena Garralda
Plasma ctDNA as a treatment response biomarker in metastatic cancers: evaluation by the RECIST working group. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Erica C Nakajima, Amber L Simpson, Jan Bogaerts, Elisabeth G E de Vries, Richard Kinh Gian Do, Elena Garralda, Gregory Goldmacher, Paul E Kinahan, Philippe Lambin, Barbara LeStage, Qin Li, Frank Po-Yen Lin, Saskia Litière, Raquel Perez-Lopez, Nicholas Petrick, Lawrence Schwartz, Lesley Seymour, Lalitha Shankar, Scott A Laurie
Tumor Size Is Not Everything: Advancing Radiomics as a Precision Medicine Biomarker in Oncology Drug Development and Clinical Care. A Report of a Multidisciplinary Workshop Coordinated by the RECIST Working Group. JCO precision oncology 8 (2024)
Erica C Nakajima, Amber L Simpson, Jan Bogaerts, Elisabeth G E de Vries, Richard Kinh Gian Do, Elena Garralda, Gregory Goldmacher, Paul E Kinahan, Philippe Lambin, Barbara LeStage, Qin Li, Frank Po-Yen Lin, Saskia Litière, Raquel Perez-Lopez, Nicholas Petrick, Lawrence Schwartz, Lesley Seymour, Lalitha Shankar, Scott A Laurie
Tumor Size Is Not Everything: Advancing Radiomics as a Precision Medicine Biomarker in Oncology Drug Development and Clinical Care. A Report of a Multidisciplinary Workshop Coordinated by the RECIST Working Group. JCO precision oncology 8 (2024)
Patricia M LoRusso, Noboru Yamamoto, Manish R Patel, Scott A Laurie, Todd M Bauer, Junxian Geng, Teffany Davenport, Michael Teufel, Jian Li, Mehdi Lahmar, Mrinal M Gounder
The MDM2-p53 antagonist BI 907828 in patients with advanced or metastatic solid tumors: results of a phase Ia, first-in-human, dose-escalation study. Cancer discovery (2023)